{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:40:07Z","timestamp":1790138407928,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.humpath.2025.106010","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:26:25Z","timestamp":1764955585000},"page":"106010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["CYP11B2 expression patterns in primary aldosteronism: Assessment of cortisol co-secretion and the B2 ratio criteria"],"prefix":"10.1016","volume":"167","author":[{"given":"Stanley M.","family":"Chen Cardenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-1115","authenticated-orcid":false,"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.106010_bib1","article-title":"Rethinking primary aldosteronism: the 2025 John H. Laragh research award","author":"Hundemer","year":"2025","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.humpath.2025.106010_bib2","article-title":"Surgical outcomes of aldosterone-producing adenoma on the basis of the histopathological findings","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.humpath.2025.106010_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coemr.2019.07.001","article-title":"The prevalence of primary aldosteronism and evolving approaches for treatment","volume":"8","author":"Yozamp","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"10.1016\/j.humpath.2025.106010_bib4","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1503\/cmaj.161486","article-title":"Primary aldosteronism: a common cause of resistant hypertension","volume":"189","author":"Kline","year":"2017","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"key":"10.1016\/j.humpath.2025.106010_bib5","article-title":"Correction to: \u201cprimary Aldosteronism: an Endocrine Society Clinical Practice Guideline.\u201d","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106010_bib6","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106010_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.humpath.2025.106010_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"1979","journal-title":"Hypertens Dallas Tex"},{"key":"10.1016\/j.humpath.2025.106010_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12882-024-03750-4","article-title":"A comparative study of postadrenalectomy hyperuricemia and renal impairment in patients with unilateral primary aldosteronism: does histopathology subtype matter?","volume":"25","author":"Fang","year":"2024","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.humpath.2025.106010_bib10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.humpath.2025.106010_bib11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2025.106010_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106010_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cen.12645","article-title":"Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy","volume":"82","author":"Volpe","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.humpath.2025.106010_bib14","first-page":"133","article-title":"Impact of immunohistochemistry on the diagnosis and management of primary aldosteronism: an important tool for improved patient follow-up","volume":"109","author":"Volpe","year":"2020","journal-title":"Scand J Surg SJS Off Organ Finn Surg Soc Scand Surg Soc"},{"key":"10.1016\/j.humpath.2025.106010_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2014.05.002","article-title":"Adrenal CYP11B1\/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies","volume":"392","author":"Nakamura","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.humpath.2025.106010_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.humpath.2025.106010_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2025.106010_bib18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/HYPERTENSIONAHA.121.17348","article-title":"Single-Center prospective cohort study on the histopathology, genotype, and postsurgical outcomes of patients with primary aldosteronism","volume":"78","author":"Meyer","year":"1979","journal-title":"Hypertens Dallas Tex"},{"key":"10.1016\/j.humpath.2025.106010_bib19","doi-asserted-by":"crossref","DOI":"10.2174\/0115665240378395250416064732","article-title":"Immunohistochemical analysis of CYP11B2 (aldosterone synthase) and evaluation of the HISTALDO classification in patients with primary aldosteronism","author":"Karadepe","year":"2025","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.humpath.2025.106010_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/ejendo\/lvaf118","article-title":"Histopathological evaluation based on CYP11B2 staining predicts outcomes in unilateral primary aldosteronism","volume":"192","author":"Goldbaum","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.humpath.2025.106010_bib21","doi-asserted-by":"crossref","first-page":"e1582","DOI":"10.1210\/clinem\/dgad747","article-title":"Correlation of histopathologic subtypes of primary aldosteronism with clinical phenotypes and postsurgical outcomes","volume":"109","author":"Ahn","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106010_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105876","article-title":"Subclassification of unilateral primary aldosteronism using an optimal cut-off value for positive CYP11B2 (aldosterone synthase) immunohistochemistry and modified histologic criteria in the Korean population","volume":"163","author":"Hong","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106010_bib23","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106010_bib24","article-title":"Clinical significance of CYP11B2 immunostaining in unilateral primary aldosteronism","volume":"13","author":"Viukari","year":"2024","journal-title":"Endocr Connect"},{"key":"10.1016\/j.humpath.2025.106010_bib25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/s41440-025-02101-6","article-title":"Speculating suitability of partial adrenalectomy for lateralized primary aldosteronism: with emphasis on partial and complete success as optimistic outcomes","volume":"48","author":"Lee","year":"2025","journal-title":"Hypertens Res Off J Jpn Soc Hypertens"},{"key":"10.1016\/j.humpath.2025.106010_bib26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ejendo\/lvaf157","article-title":"Improving diagnosis in primary aldosteronism using HISTALDO and nodule size metrics","volume":"193","author":"Solhusl\u00f8kk H\u00f6se","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.humpath.2025.106010_bib27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/HYPERTENSIONAHA.120.15328","article-title":"Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success","volume":"76","author":"Peng","year":"1979","journal-title":"Hypertens Dallas Tex"},{"key":"10.1016\/j.humpath.2025.106010_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12902-020-0490-0","article-title":"Clinical characterization of patients with primary aldosteronism plus subclinical Cushing's syndrome","volume":"20","author":"Yasuda","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.humpath.2025.106010_bib29","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1210\/jc.2018-00617","article-title":"Cortisol excess in patients with primary aldosteronism impacts left ventricular hypertrophy","volume":"103","author":"Adolf","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106010_bib30","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0043","article-title":"Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes","volume":"12","author":"Araujo-Castro","year":"2023","journal-title":"Endocr Connect"},{"key":"10.1016\/j.humpath.2025.106010_bib31","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1210\/jc.2019-00299","article-title":"Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion","volume":"104","author":"Gerards","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106010_bib32","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1210\/clinem\/dgab698","article-title":"Selective glucocorticoid replacement following unilateral adrenalectomy for hypercortisolism and primary aldosteronism","volume":"107","author":"DeLozier","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2025.106010_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1369582","article-title":"The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.humpath.2025.106010_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/cen.14958","article-title":"Immunohistochemical staining seems mandatory for individualizing and shortening follow-up in unilateral primary aldosteronism","volume":"99","author":"Gunnarsdottir","year":"2023","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.humpath.2025.106010_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279682","article-title":"Ectopic localization of CYP11B1 and CYP11B2-expressing cells in the normal human adrenal gland","volume":"17","author":"Duparc","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2025.106010_bib36","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.6_suppl.487","article-title":"Clinicopathological features of lipid cell variant of urothelial carcinoma","volume":"36","author":"Hayashi","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.106010_bib37","doi-asserted-by":"crossref","first-page":"9042","DOI":"10.3390\/ijms23169042","article-title":"Clinical translationality of KCNJ5 mutation in aldosterone producing adenoma","volume":"23","author":"Kitamoto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2025.106010_bib38","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/ERC-13-0466","article-title":"Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas","volume":"21","author":"Dutta","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2025.106010_bib39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:42:19Z","timestamp":1773870139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725002977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"alternative-id":["S0046817725002977"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106010","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP11B2 expression patterns in primary aldosteronism: Assessment of cortisol co-secretion and the B2 ratio criteria","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106010"}}